Literature DB >> 22456454

Utility of HbA1c for diagnosis of gestational diabetes mellitus.

Rajesh Rajput1, Meena Rajput, Smiti Nanda.   

Abstract

OBJECTIVE: To evaluate the utility of HbA(1c) in combination with OGTT for diagnosis of GDM.
MATERIALS AND METHODS: 607 pregnant women with their estimated gestational age between 24 and 28 weeks were evaluated for GDM using OGTT based on ADA criteria. HbA(1c) was also done at the same time.
RESULTS: The mean HbA(1c) value in women with GDM was significantly higher than women without GDM (5.73 ± 0.34% compared to 5.34 ± 0.35%). The area under ROC curve of HbA(1c) to detect GDM was 0.805 and an HbA(1c) cutoff value of ≥5.95% had sensitivity of 28.6% and specificity of 97.2% in diagnosing GDM while an HbA(1c) cutoff value of ≥5.45% had sensitivity of 85.7% and specificity of 61.1% in diagnosing GDM. For women with an HbA(1c) value between 5.45% and 5.95%, an OGTT should be performed to correctly identify women with GDM. Using this methodology 85.7% of the GDM cases would have been detected and only 2.8% of normal women would have been wrongly labeled as having GDM. Also, this methodology would have obviated an OGTT in 61.8% women in our study.
CONCLUSION: HbA(1c) in combination with OGTT can obviate the need of OGTT in almost two-thirds of women with GDM.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22456454     DOI: 10.1016/j.diabres.2012.02.018

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  28 in total

Review 1.  Is There a Role for HbA1c in Pregnancy?

Authors:  Ruth C E Hughes; Janet Rowan; Chris M Florkowski
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

Review 2.  Application of glycated hemoglobin in the perinatal period.

Authors:  Haiyan Yu; Xiaorong Qi; Xiaodong Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

4.  Impact of inflammatory factors, hemoglobin A1c, and platelet parameters in gestational diabetes mellitus.

Authors:  Lan-Lan Xiang; Chen Chen; Qian-Yi Wang; Yi-Tian Zhu; Ya-Jun Chen; Yu Zeng
Journal:  Arch Gynecol Obstet       Date:  2022-04-01       Impact factor: 2.344

5.  Comparison of Diagnostic Accuracy of Non-fasting DIPSI and HbA1c with Fasting WHO Criteria for Diagnosis of Gestational Diabetes Mellitus.

Authors:  Pikee Saxena; Puja Verma; Binita Goswami
Journal:  J Obstet Gynaecol India       Date:  2017-02-20

Review 6.  Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis.

Authors:  Katherine T Li; Shilpa Naik; Mallika Alexander; Jyoti S Mathad
Journal:  Acta Diabetol       Date:  2018-03-26       Impact factor: 4.280

7.  The relationship between glycated hemoglobin and blood glucose levels of 75 and 100 gram oral glucose tolerance test during gestational diabetes diagnosis.

Authors:  Meral Mert; Serhat Purcu; Ozlem Soyluk; Yildiz Okuturlar; Pinar Karakaya; Gonca Tamer; Mine Adas; Murat Ekin; Sami Hatipoglu; Oznur Sari Ure; Ozlem Harmankaya; Abdulbaki Kumbasar
Journal:  Int J Clin Exp Med       Date:  2015-08-15

8.  Diagnostic value of glycemic markers HbA1c, 1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus.

Authors:  Baris Saglam; Sezer Uysal; Sadik Sozdinler; Omer Erbil Dogan; Banu Onvural
Journal:  Ther Adv Endocrinol Metab       Date:  2017-11-23       Impact factor: 3.565

9.  HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus.

Authors:  Paula Breitenbach Renz; Gabriela Cavagnolli; Letícia Schwerz Weinert; Sandra Pinho Silveiro; Joíza Lins Camargo
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

10.  HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome.

Authors:  Ingrid Hov Odsæter; Arne Åsberg; Eszter Vanky; Sven Magnus Carlsen
Journal:  BMC Endocr Disord       Date:  2015-08-06       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.